Analyst Information
Steven Mah, Ph.D.Sr. Research AnalystSteven Mah is a director and senior research analyst at Piper Sandler covering the Diagnostics & Life Science Tools sector. Prior to joining the sell-side, Mah spent 13 years in Piper Sandler’s Healthcare investment banking group, covering a broad range of investment banking activities in the Diagnostics and Life Sciences Tools space, including mergers & acquisitions, public and private financings. Before beginning his investment banking career, Mah was a scientist and program manager at Sequenom. Mah earned a doctorate in molecular biology from the Salk Institute and graduated with a bachelor’s degree in molecular biology from UCLA and received a Master of Business Administration degree from the Johnson School of Business at Cornell University. |
Universe Coverage: Healthcare: Medical Diagnostics | |
AXDX | Accelerate Diagnostics, Inc. |
AVTR | Avantor, Inc. |
CDNA | CareDx, Inc. |
FLDM | Fluidigm Corporation |
FLGT | Fulgent Genetics, Inc. |
HSKA | Heska Corporation |
ILMN | Illumina, Inc. |
LMNX | Luminex Corporation |
VIVO | Meridian Bioscience Inc. |
MYGN | Myriad Genetics, Inc. |
NTRA | Natera, Inc. |
OCX | OncoCyte Corp. |
OCDX | Ortho Clinical Diagnostics Holdings Plc |
OXFD | Oxford Immunotec Global PLC |
PACB | Pacific Biosciences of California, Inc. |
PROG | Progenity, Inc. |
QDEL | Quidel Corporation |